Le Lézard
Classified in: Health
Subjects: TDS, WOM, FVT

Univfy to Present at Women's Health Innovation Summit and Precision Medicine World Conference


LOS ALTOS, Calif., Nov. 12, 2019 /PRNewswire/ -- Univfy, an AI and machine learning platform company with a mission to expand in-vitro fertilization (IVF) access, will be presenting at the upcoming conferences:

Women's Health Innovation Summit 2019:
When: December 3, 2019 | 3:30 p.m. ET
Where: Wyndham Boston Beacon Hill | 5 Blossom St. Boston, MA 02114
Title: Machine Learning and AI to Empower Women's Fertility

Precision Medicine World Conference 2020:
Where: Santa Clara Convention Center | 5001 Great America Pkwy. Santa Clara, CA 95054
Artificial Intelligence and Data Sciences
|Track 7:
When: January 22, 2020 | 2:30 p.m. PT
Where: Great America Meeting Room K
Clinical Diagnostics | Track 3:
When: January 23, 2020 | 4:15 p.m. PT
Where: Hall C

About Univfy:
The proprietary Univfy AI Platform for IVF makes it easy for women and couples to access the most effective and safest fertility treatment. It is the only highly-scalable AI platform that provides scientifically validated, personalized reports that counsel patients from diverse demographics about their probability of having a baby. Our goal is to improve the experience for patients who need help to build their families and to make it easy for providers to improve their efficiency.

About Univfy CEO & Co-Founder Mylene Yao:
Dr. Yao has led Univfy from founding through stages of technology invention and commercialization and now focuses on scaling Univfy's business. She has over 20 years of experience in clinical and scientific research in reproductive medicine. Prior to founding Univfy, she was on the faculty at Stanford University, where she led NIH-funded fertility and embryo genetics research and developed the Univfy technology with the academic founding team. She is also co-inventor on Univfy's global IP portfolio, comprising patents issued in the US and other countries.

Investor Contact: [email protected]
Media Contact: [email protected]

 

SOURCE Univfy Inc.


These press releases may also interest you

at 07:30
Optimi Health Corp. (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, proudly announces its role as a Presenting Sponsor at the highly...

at 07:30
Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of...

at 07:30
Quipt Home Medical Corp. (the "Company") ?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024...

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....



News published on and distributed by: